Villa Steps Up to Show Appreciation for Staff Heroes: New Villa Hero Foundation Formed for “Heroes Helping Heroes”
Share Article
Throughout the trauma and challenges of the COVID-19 pandemic, employees of Villa Healthcare have worked tirelessly to serve nursing home residents every day. To show appreciation for that hero-level commitment, Villa stepped up to create several initiatives to recognize employees’ contributions on the front lines of health care.
“We wanted to thank our employees for their unwavering commitment to our residents throughout this pandemic. They are all heroes,” said Mark Berger, CEO of Villa Healthcare. LINCOLNWOOD, Ill. (PRWEB) February 22, 2021 Throughout the trauma and challenges of the COVID-19 pandemic, employees of Villa Healthcare have worked tirelessly to serve nursing home residents every day. To show appreciation for that hero-level commitment, Villa stepped up to crea
Nursing homes, senior citizen advocates say COVID-19 vaccinations will boost optimism
Nursing homes ready for second dose of vaccines By Sabrina Wilson | January 5, 2021 at 7:54 PM CST - Updated January 5 at 9:17 PM
NEW ORLEANS (WVUE) - The nursing home industry as well as advocates for senior citizens living outside of long-term care facilities are thrilled vaccinations among older Louisianans are increasing. And they believe access to the shots will improve the emotional outlook of many people.
Deacon Jeff Tully is the CEO of the Notre Dame Health System which is a ministry of the Archdiocese of New Orleans. The Notre Dame Health System owns and operates Chateau de Notre Dame, Wynhoven Health Care Center, and Our Lady of Wisdom Health Care Center.
Actinium Says DMC Recommends Phase 3 SIERRA Trial Continue To Full Enrolment Of 150 Patients
WASHINGTON (dpa-AFX) - Actinium Pharmaceuticals, Inc. (ATNM) said Tuesday that the independent Data Monitoring Committee or DMC has completed the single ad hoc interim analysis of the pivotal Phase 3 SIERRA study of Iomab-B for bone marrow transplant (BMT) conditioning in patients aged above 55 with active relapsed or refractory Acute Myeloid Leukemia (R/R AML).
The SIERRA trial is a randomized, controlled study evaluating outcomes of patients receiving Iomab-B and a BMT compared to outcomes of patients on the control arm, who may proceed to BMT if they achieve a required complete remission (CR).
Coronavirus vaccine s arrival in Louisiana nursing homes marks end of dark period: We re hopeful nola.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from nola.com Daily Mail and Mail on Sunday newspapers.